ClinicalTrials.govpublic full text
IMCY-0141 Safety and Efficacy in Multiple Sclerosis - ISEMIS Study
multiple sclerosis, relapsing-remitting, rr-ms, relapsing-remitting multiple sclerosis, multiple sclerosis, synthetic peptide, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 902459
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.